After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Cassava Sciences Inc is $157.48M. A total of 9.13 million shares were traded on the day, compared to an average of 1.74M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, SAVA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 1 BUYs and 3 SELLs from insiders. Insiders purchased 50,000 shares during that period but sold 65,800.
In the most recent transaction, Barry Richard bought 7,172 shares of SAVA for 2.28 per share on Sep 22 ’25. After the transaction, the President & CEO now owns 714,675 company shares. In a previous transaction on Sep 18 ’25, Barry Richard bought 190,633 shares at 2.24 per share. SAVA shares that President & CEO owns now total 660,195.
Among the insiders who bought shares, Barry Richard acquired of 47,308 shares on Sep 19 ’25 at a per-share price of $2.29. This resulted in the President & CEO holding 707,503 shares of SAVA after the transaction. In another insider transaction, Kupiec James William sold 4,000 shares at $3.87 per share on Nov 29 ’24. Company shares held by the Chief Medical Officer now total 0.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SAVA has a high of $33.98 and a low of $1.15.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SAVA’s latest balance sheet shows that the firm has $233.44M in Cash & Short Term Investments as of fiscal 2021. There were $236.00k in debt and $12.53M in liabilities at the time. Its Book Value Per Share was $1.82, while its Total Shareholder’s Equity was $253.91M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SAVA is Buy with a score of 1.00.
